The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Incyte Corp

Nasdaq: INCY
Last

(U.S.) $131.57

Today's change+0.36 +0.27%
Updated February 27 10:12 AM EST. Delayed by at least 15 minutes.
 

Incyte Corp

Nasdaq: INCY
Last

(U.S.) $131.57

Today's change+0.36 +0.27%
Updated February 27 10:12 AM EST. Delayed by at least 15 minutes.

Incyte Corp Hits New 100-day High

Incyte Corp is up today by (U.S.)$0.36 or 0.27% to (U.S.)$131.57 and setting a new 100-day high. Over the last five days, shares have gained 9.20% and 31.22% year to date. Shares have outperformed the S&P 500 by 55.51% during the last year.

Key company metrics

  • Open(U.S.) $131.88
  • Previous close(U.S.) $131.21
  • High(U.S.) $132.79
  • Low(U.S.) $130.24
  • Bid / Ask(U.S.) $131.56 / (U.S.) $131.58
  • YTD % change+31.22%
  • Volume1,069,595
  • Average volume (10-day)2,057,670
  • Average volume (1-month)1,626,770
  • Average volume (3-month)1,467,512
  • 52-week range(U.S.) $60.30 to (U.S.) $132.79
  • Beta0.85
  • Trailing P/E244.34×
  • P/E 1 year forward248.36×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.54
Updated February 27 10:12 AM EST. Delayed by at least 15 minutes.
S&P TSX0.13%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue326269246263
Total other revenue--------
Total revenue326269246263
Gross profit307249234257
Total cost of revenue2020126
Total operating expense284247202227
Selling / general / administrative96766765
Research & development162143120157
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total782--
Operating income42224536
Interest income (expense), net non-operating-9-9-10-10
Gain (loss) on sale of assets--------
Other--------
Income before tax9383524
Income after tax9373424
Income tax, total1110
Net income9373424
Total adjustments to net income--------
Net income before extra. items9373424
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items9373424
Inc. avail. to common incl. extra. items9373424
Diluted net income9373424
Dilution adjustment00--0
Diluted weighted average shares195194193193
Diluted EPS excluding extraordinary itemsvalue per share0.050.190.180.12
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.050.190.180.12